AbbVie sues Amgen for patent infringement

08-08-2016

AbbVie sues Amgen for patent infringement

blackboard1965 / Shutterstock.com

AbbVie has sued Amgen saying its proposed biosimilar for the Humira (adalimumab) drug infringes 61 patents.


AbbVie, Amgen, patents, Humira, adalimumab, FDA, BPCIA

LSIPR